Evidence map›Paper›PMID 31217941›Full record

ArticleTherapeutic advances in hematology2019

Chronic myelomonocytic leukemia associated with myeloid sarcomas and

Faris Matanes, Basel M A AbdelAzeem, Gaurav Shah, Vishnu Reddy, Ayman Saad, Nikolaos Papadantonakis

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Faris MatanesJordan University of Science and Technology, Irbid, Jordan; and Vascular Biology and Hypertension Program, University of Alabama at Birmingham, USA.
Basel M A AbdelAzeemEldemerdash Hospital, Faculty of Medicine-Ain Shams University, Cairo, Egypt.
Gaurav ShahInternal Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Vishnu ReddyDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Ayman SaadDivision of Hematology, Ohio State University, Columbus, OH, USA.
Nikolaos PapadantonakisDivision of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, 1720 2nd Avenue South, NP 2540, Birmingham, AL 35294-3300, USA.ORCID https://orcid.org/0000-0003-1943-6421
University of Alabama at Birmingham · USAin Shams University Hospital · EGJordan University of Science and Technology · JOThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a case of chronic myelomonocytic leukemia (CMML) associated with myeloid sarcomas. The CMML also harbored a

Indexed as

chronic myelomonocytic leukemiamyelodysplastic syndrome/myeloproliferative neoplasmmyeloid sarcomaNPM1 mutation

Identifiers

PMID31217941
PMCPMC6557017
OpenAlexW2964895539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.